Indel derived tumour-specific neoantigens: The Lancet Oncology: Aug 2017
Samra Turajlic discusses the contribution of small insertions and deletions to tumour-specific antigen analyses.
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv